CardioDx

company

About

CardioDx is a cardiovascular genomic diagnostics company providing clinicians with information to enhance patient care.

  • 51 - 100

Details

Last Funding Type
Private Equity(PE)
Last Funding Money Raised
$58M
Industries
Biotechnology,Genetics,Health Care,Health Diagnostics,Pharmaceutical
Founded date
Jan 1, 2004
Number Of Employee
51 - 100
Operating Status
Active

CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failures.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$77M
CardioDx has raised a total of $77M in funding over 2 rounds. Their latest funding was raised on Aug 27, 2012 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 27, 2012 Private Equity(PE) $58M 1 Detail
Jul 21, 2006 Series B $19M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
CardioDx is funded by 2 investors. JP Morgan Chase and TPG are the most recent investors.
Investor Name Lead Investor Funding Round
JP Morgan Chase Private Equity(PE)
TPG Series B